Abstract:The U.S. dollar edged slightly lower on Thursday in reduced European trading, as the U.S. and Italy joined a list of countries to require COVID-19 testing by incoming travelers from China.

The U.S. dollar edged slightly lower on Thursday in reduced European trading, as the U.S. and Italy joined a list of countries to require COVID-19 testing by incoming travelers from China.
As of 03:37 ET (08:37 GMT), the U.S. Dollar Index - which tracks the greenback against a basket of six other currencies - was lower by 0.22% to 104.24. That marked a paring back from earlier gains spurred on by a rise in benchmark U.S. 10-year Treasury yields, which hit a more than one-month high overnight.
Authorities in Washington and Rome, as well as India, have now said that they will make people coming into these nations from China take COVID-19 tests.
Beijing had previously announced that it will remove quarantine rules for inbound travelers starting on January 8, sparking hopes that the world's second-largest economy may be moving past an era of strict coronavirus regulations. But this optimism is showing signs of fading as cases spread across the country.
The Chinese offshore yuan moved up more than 0.2% to 6.9791 against the dollar. The British pound rose 0.26% to 1.2044, but was hovering just under its December low of 1.1993, while the euro also bumped up 0.27% to 1.0637.
Presently, the Japanese yen rallied to 133.61 per dollar, nearly canceling out a loss of 0.7% on Wednesday. Analysts at Resona Holdings said an announcement from the BOJ earlier in December that it will loosen its 10-year Japanese government bond yield band has fuelled speculation that the central bank will tighten monetary policy further next year.
Somewhere the Russian ruble touched its lowest mark against the U.S. dollar since April, as worries increase that key export revenues will be hit by sanctions on the country's oil and gas.

The visible fee in an MT4 white label proposal is rarely the real cost of operating it. For an existing broker, the decision is not simply whether an MT4 white label platform is “cheap” or “expensive.” The real question is whether the commercial model remains viable after integration, support, data, client migration, compliance, and exit costs are included. That is why an MT4 white label cost review should be built as a 24- to 36-month operating case. It should compare three credible choices: 1. Keep the present MT4 setup and improve its weakest controls. 2. Replace the MT4 white label provider but retain the client proposition. 3. Migrate selected clients or products to another platform while running MT4 in parallel. This guide explains how to build that case without relying on headline prices or generic vendor claims.

The decision to switch white label providers or migrate to a modern white label trading platform is no longer a luxury for growth-minded brokers—it's a strategic necessity for survival in 2026. The convergence of technological stagnation, regulatory evolution, and shifting client expectations has created a perfect storm.

ABET, a Bulgaria-based brokerage firm, faces severe allegations from users for the reportedly inefficient way it handles their funds. While some alleged illegitimate account blocks by the broker, others reported fund scams and trade manipulations. These ABET reviews have raised question marks over the broker’s legitimacy.

22K Trader, a United Kingdom-based brokerage entity, is facing severe fund scam allegations from Indian users, in particular. One user reported losing as high as $26,500 on the platform. Similarly, other users have claimed different loss amounts while also criticizing the forced trade execution by the broker. In this 22K Trader review, we have examined several user allegations and provided the regulatory framework the broker operates under.